What antibiotics are best in typhoid and paratyphoid infections? Evidence update - Summary of a Cochrane Review by Effective Health Care Research Consortium
Background 
Multiple-drug resistant (MDR) strains of typhoid and 
paratyphoid limit antibiotic choice.  
Inclusion criteria 
Studies:  
Randomized controlled trials. 
Participants: 
People with microbiologically confirmed typhoid or 
paratyphoid fever.  
Intervention: 
Intervention: fluoroquinolones. 
Control: different fluoroquinolones, different regimens, 
other antibiotics.   
Outcomes: 
Clinical treatment failure, microbiological treatment 
failure, relapse, fever clearance time, hospital stay, 
adverse events. 
Results 
• Thirty-eight trials were included; 27 in adults. Sixteen 
trials had adequate allocation concealment. Most trials 
had small sample sizes. 
• In adults without identified MDR strains, clinical 
treatment failure between fluoroquinolones and 
chloramphenicol was similar (594 participants, 9 
trials) but fluoroquinolones reduced relapse (odds 
ratio 0.14, 95% confidence interval 0.04 to 0.50; 467 
participants, 6 trials). There was no significant 
difference in the occurrence of adverse events. 
• Fluoroquinolones were better than amoxicillin, 
ampicillin and cefixime in small trials examining 
clinical failure and relapse. 
• There were fewer clinical failures with 
fluoroquinolones than cefriaxone (OR 0.08, 95% CI 
0.01 to 0.45; 120 participants, 3 trials), but there was 
no significant difference in microbiological failure or 
relapse. 
• In comparisons between fluoroquinolones, 
norfloxacin increased the risk of clinical failure 
compared with other fluoroquinolones: pefloxacin 
(OR 30.60, 95% CI 5.75 to 162.86, 200 participants, 
3 trials), ofloxacin (OR 28.15, 95% CI 4.80 to 165.14; 
123 participants, 3 trials), and enoxacin (OR 4.15, 
95% CI 1.77 to 9.76; 142 participants, 2 trials). 
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What antibiotics are best in typhoid and paratyphoid infections?  
For adults fluoroquinolones seem best in adults, but data in children are limited. 
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Authors’ conclusions 
Implications for practice:  
In adults, fluoroquinolones may perform better than chloramphenicol, ceftriaxone or cefixime. However, trials 
were small and of variable methodological quality. No conclusions could be made for superiority of any particular 
duration of fluoroquinolone therapy and no firm conclusions can be made regarding the use of fluoroquinolones in 
children.  
Implications for research: 
Larger or multicentred well-designed trials of fluoroquinolones in children are needed, particularly in outpatient 
settings with monitoring of adverse events. 
